We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Amendment of the Drug Administration Law of the People's Republic of China (Draft for Comment) proposes to cancel the GMP certification and GSP certification, and change the APIs and excipients to be approved together with pharmaceutical products.